Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART

NCT01869634 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus Infection

Interventions

DRUG: darunavir with ritonavir and fixed-dose viread+emtricitabine daily

Sponsor

University of California, Davis